Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
SNN - Smith & Nephew SNATS, Inc.
Market Cap 12.80B P/E 57.45 EPS this Y -24.70% Ern Qtrly Grth 97.80%
Income 263M Forward P/E 15.50 EPS next Y 20.80% 50D Avg Chg -5.00%
Sales 5.55B PEG -2.44 EPS past 5Y 0.32% 200D Avg Chg 2.00%
Dividend 1.00% Price/Book 12.12 EPS next 5Y -8.00% 52W High Chg -11.00%
Recommedations 2.00 Quick Ratio 0.67 Shares Outstanding 437.17M 52W Low Chg 35.00%
Insider Own 0.03% ROA 4.27% Shares Float 862.75M Beta 0.51
Inst Own 7.58% ROE 5.02% Shares Shorted/Prior 1.98M/2.40M Price 29.30
Gross Margin 70.14% Profit Margin 4.74% Avg. Volume 866,851 Target Price 30.50
Oper. Margin 14.46% Earnings Date Aug 1 Volume 964,860 Change -2.17%
Healthcare | Medical Devices | United Kingdom
About Smith & Nephew SNATS, Inc.

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Smith & Nephew SNATS, Inc. News
04/22/24 With 83% ownership of the shares, Smith & Nephew plc (LON:SN.) is heavily dominated by institutional owners
04/18/24 Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention
04/08/24 Smith+Nephew signs exclusive distribution agreement to provide unique NAVBIT SPRINT™ solution in Australia
04/08/24 Here’s Why You Should Invest in Smith & Nephew plc (SNN)
10:13 AM Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)
04/03/24 Investors five-year losses continue as Smith & Nephew (LON:SN.) dips a further 5.6% this week, earnings continue to decline
04/01/24 Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds
04/01/24 Smith & Nephew PLC's Dividend Analysis
03/25/24 Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner
03/18/24 Some Investors May Be Worried About Smith & Nephew's (LON:SN.) Returns On Capital
03/13/24 7 Robotic Surgery Stocks to Buy for the Future of Healthcare
03/01/24 Smith & Nephew plc Just Missed EPS By 38%: Here's What Analysts Think Will Happen Next
02/28/24 Smith & Nephew plc (NYSE:SNN) Q4 2023 Earnings Call Transcript
02/28/24 Smith+Nephew and U.S. Army Institute of Surgical Research to engage in Master Cooperative Research and Development Agreement
02/27/24 Basic Materials Roundup: Market Talk
02/27/24 Health Care Roundup: Market Talk
02/21/24 Are Investors Undervaluing Smith & Nephew SNATS (SNN) Right Now?
02/14/24 Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
02/13/24 Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting
02/12/24 Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting
SNN Chatroom

User Image Stock_Titan Posted - 04/18/24

$SNN Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention https://www.stocktitan.net/news/SNN/smith-nephew-announces-new-evidence-supporting-allevyn-life-foam-gg35gqpobk0t.html

User Image Stock_Titan Posted - 1 month ago

$SNN Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds https://www.stocktitan.net/news/SNN/smith-nephew-introduces-the-renasys-edge-negative-pressure-wound-ocu143i2gwu5.html

User Image Stock_Titan Posted - 03/25/24

$SNN Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner https://www.stocktitan.net/news/SNN/smith-nephew-teams-up-with-ufc-to-be-first-ever-preferred-sports-6c8z7tl4gi83.html

User Image Stock_Titan Posted - 02/28/24

$SNN Smith+Nephew and U.S. Army Institute of Surgical Research to engage in Master Cooperative Research and Development Agreement https://www.stocktitan.net/news/SNN/smith-nephew-and-u-s-army-institute-of-surgical-research-to-engage-3c6woveh5zd8.html

User Image TJmaximus Posted - 02/27/24

$SNN agili-c

User Image michelleObamasPen15 Posted - 02/27/24

$SNN I'm thinking big up on earnings news. I know a few employees and they have been getting their balls squeezed by management. Reps have to earn every dollar.

User Image swingingtech Posted - 02/21/24

$ISRG $PDYN $SNN https://wallstreetwaves.com/3-millionaire-maker-robotics-stocks-to-buy-in-february-2024/

User Image Stock_Titan Posted - 02/13/24

$SNN Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting https://www.stocktitan.net/news/SNN/smith-nephew-announces-commercial-launch-of-its-aetos-shoulder-snzod8rn7l83.html

User Image Stock_Titan Posted - 02/12/24

$SNN Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting https://www.stocktitan.net/news/SNN/smith-nephew-to-showcase-leading-innovative-ai-driven-robotic-ea4yvcw1tsx2.html

User Image Stock_Titan Posted - 02/12/24

$SNN Smith+Nephew unveils expanded Sports Medicine portfolio to enable biological healing at AAOS 2024 Annual Meeting https://www.stocktitan.net/news/SNN/smith-nephew-unveils-expanded-sports-medicine-portfolio-to-enable-rqp3q75gdorj.html

User Image TJmaximus Posted - 01/23/24

$SNN https://www.smith-nephew.com/en/news/2024/01/10/20240110---sn-completes-acquisition-of-novel-cartilage-regeneration

User Image StockAutomatePro Posted - 01/20/24

$SNN The stock looks poised for growth based on the chart. We alerted the BUY signal at $27.1 and we were able to close this one with profit at $28.17 📊 See more details at StockAutomate.com

User Image StockAutomatePro Posted - 01/19/24

$SNN Stock market is looking optimistic based on the chart. We alerted the BUY signal at $27.1 and we were able to close this one with profit at $28.06 📊

User Image Inamar06 Posted - 01/18/24

$SNN Comeback?

User Image cctranscripts Posted - 01/17/24

Report of foreign issuer [Rules 13a-16 and 15d-16] https://www.conferencecalltranscripts.org/summary/?id=12871956 $SNN

User Image STCKPRO Posted - 01/14/24

$SNN NEW ARTICLE : Australia's approach to musculoskeletal injury care and reimbursement demands rethink: Report https://www.stck.pro/news/SNN/72691297/

User Image ChartMill Posted - 01/13/24

A very nice breakout setup pattern for $TT, $CALM, $SNN, $EFG and $AMD, will they break out? https://www.chartmill.com/stock/stock-screener?sid=202&f=v1_50b500,atrpct_a_1,sl_ta_7_X,sl_se_7_X,p_pg20,exch_us&s=se&v=3&utm_source=Technical_Breakout_Setups&utm_medium=stocktwits&utm_campaign=screen

User Image Stock_Titan Posted - 01/11/24

$SNN New study confirms Smith+Nephew’s REGENETEN™ Bioinductive Implant reduces full-thickness rotator cuff re-tear rates¹ by 68% https://www.stocktitan.net/news/SNN/new-study-confirms-smith-nephew-s-regeneten-bioinductive-implant-xmzjy9na09wb.html

User Image DonCorleone77 Posted - 01/11/24

$SNN Smith & Nephew announces results for its REGENETEN Bioinductive Implant Smith+Nephew announces results for its REGENETEN Bioinductive Implant from a recently completed randomized controlled trial, RCT. Published online in Arthroscopy in December, the report concluded that at one-year, medium and large full-thickness rotator cuff tears repaired and augmented with the REGENETEN Bioinductive Implant had better tendon healing compared to the standard of care, as evidenced by: A significantly lower re-tear rate; A three times lower risk of re-tear; No difference in the number of serious or minor complications. The blinded, multi-centre RCT compared the healing rate of full-thickness rotator cuff tears repaired with and without augmentation with the REGENETEN Bioinductive Implant.

User Image cctranscripts Posted - 01/10/24

Report of foreign issuer [Rules 13a-16 and 15d-16] https://www.conferencecalltranscripts.org/summary/?id=12856382 $SNN

User Image shortvolumes Posted - 01/10/24

The short sale volume (not short interest) for $SNN on 2024-01-09 is 50%. http://shortvolumes.com/?t=SNN via @shortvolumes

User Image cctranscripts Posted - 4 months ago

Smith & Nephew SNATS just filed its Report of foreign issuer [Rules 13a-16 a http://www.sec.gov/Archives/edgar/data/845982/000165495424000160/0001654954-24-000160-index.htm $SNN

User Image cctranscripts Posted - 4 months ago

Report of foreign issuer [Rules 13a-16 and 15d-16] https://www.conferencecalltranscripts.org/summary/?id=12833430 $SNN

User Image EarningsInsider Posted - 12/13/23

Smith & Nephew Sees Short Interest Decrease from 1,670,000 shares to 1,080,000 shares. $SNN https://www.marketbeat.com/stocks/NYSE/SNN/shor

User Image tickeron Posted - 12/06/23

This is why Hedge Funds use A.I. $SNN MACD Histogram turned negative on December 5, 2023. View odds of downtrend. https://srnk.us/go/4934544

User Image cctranscripts Posted - 12/06/23

Report of foreign issuer [Rules 13a-16 and 15d-16] https://www.conferencecalltranscripts.org/summary/?id=12768896 $SNN

User Image stockilluminati Posted - 12/06/23

$SNN https://www.stockilluminati.com/snn/filings.php - Smith & Nephew SNATS, Inc. Common Stock files form 6-K today, check out the details.

User Image cctranscripts Posted - 12/05/23

Report of foreign issuer [Rules 13a-16 and 15d-16] https://www.conferencecalltranscripts.org/summary/?id=12764715 $SNN

User Image cctranscripts Posted - 11/29/23

Report of foreign issuer [Rules 13a-16 and 15d-16] https://www.conferencecalltranscripts.org/summary/?id=12747336 $SNN

User Image cctranscripts Posted - 11/22/23

Report of foreign issuer [Rules 13a-16 and 15d-16] https://www.conferencecalltranscripts.org/summary/?id=12730960 $SNN

Analyst Ratings
Bernstein Outperform Oct 4, 23
Redburn Partners Neutral Mar 4, 22
Canaccord Genuity Buy Apr 30, 21
Bernstein Outperform Dec 18, 20
Canaccord Genuity Buy Oct 30, 20
CFRA Hold May 7, 20
CFRA Hold Feb 21, 20
Bernstein Outperform Nov 12, 19
Canaccord Genuity Buy Apr 25, 19